SEGAL ROBERT-MD 5

5 · DISCOVERY LABORATORIES INC /DE/ · Filed Feb 9, 2011

Insider Transaction Report

Form 5
Period: 2010-12-31
SEGAL ROBERT-MD
Sr VP, Chief Medical Officer
Transactions
  • Award

    Common Stock

    2010-06-30$2.85/sh+723$2,0613,930 total(indirect: By Trust)
Holdings
  • Common Stock

    8,635
Footnotes (2)
  • [F1]All share amounts are adjusted to reflect a 1-for-15 reverse split that was effective December 28, 2010
  • [F2]Transaction reported on Table 1 represents issuer's matching stock contribution pursuant to its 401(k) plan.

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT